Exam 1 Flashcards
(413 cards)
Echinacea (purple coneflower root)
Pharmacologic: Activation of cell mediated immunity. Periop Concerns: allergic reaction, decreased immunosuppressant effects, poss. immunosuppression with longterm use
Ephedra (mahuang)
Pharmacologic: Directly/indirectly Increases heart rate and blood pressure Periop Concerns: Ischemia, Arhythmias, depleted catecholamines, interacts with MAOI D/C: 24 hours prior
Garlic (ajo)
Pharmacodynamics: Inhibits platelet aggregation, increases fibrinolysis, antihypertensive activity D/C: 7 days prior
Ginger
Pharmacodynamics: Anti-emetic, antiplatelet aggregation
Ginkgo (duck-foot tree, silver apricot)
Pharmacodynamics: Inhibits platelet activating factor D/C: 36 hours prior
Ginseng
Pharmacodynamics: Lowers blood sugar, inhibits platelet aggregation, increased PT/PTT in animals Periop Concerns: May decrease anticoagulant effect of warfarin D/C: 7 days prior
Green tea
Pharmacodynamics: Inhibits platelet aggregation and thromboxane A2 formation Periop Concerns: May decrease anticoagulant effect of warfarin D/C: 7 days prior
Kava (awa, intoxicating pepper, kawa)
Pharmacodynamics: sedation and anxiolysis Periop Concerns: May increase anesthetic effect, long term use increases anesthetic requirement D/C: 24 hours prior
Saw palmetto (dwarf palm)
Pharmacodynamics: Inhibits 5 alpha reductase (responsible for turning testosterone into DHT) and cyclooxygenase
St. John’s Wart (goat weed, hardhat, amber)
Pharmacodynamics: Inhibits neurotransmitter reuptake, MAO inhibition unlikely Periop Concerns: Decrease serum dig levels, delays emergence, induction CP450 D/C: 5 Days
Valerian (vandal root, all heart, garden heliotrope)
Pharmacodynamics: Sedation Periop Concerns: Increase anesthetic effect, acute benzo-like withdrawal, long term use increases anesthetic requirements
Anesthesia considerations for ACE inhibitors (-pril) Intraop concerns, management and D/C issues
Intraop Concerns: Intolerance of hypovolemia, hypotension Management: Optimize hydration and moderate doses of vasporessors D/C issues: Brief interruption tolerated well, may improve regional blood flow and oxygen delivery and preserve renal function, HOLD am dose day of surgery
Anesthesia considerations for beta blockers (-lol) Intraop concerns, management and D/C issues
Intraop Concerns: D/C may increase cardiovascular morbidity and develop of withdrawal symptoms Management: Hydration D/C issues: Should be continued on day of surgery
Anesthesia considerations for Calcium channel blockers Intraop concerns, management and D/C issues
Intraop concerns: Decrease. SVR and BP d/t peripheral vasodilation; Neg. into and chronotropic effects Management: Hydration and phenylephrine as needed to maintain atrial pressure D/C issues: Caution in patients with left ventricular dysfunction shown by EF <40%
Anesthesia considerations for diuretics Intraop concerns, management and D/C issues
Intraop concerns: hypokalemia and hypovolemia Management: Preop potassium levels, hydration D/C issues: Pts rarely show issues with holding morning dose, might be desirable to continue if part of tx for chronic renal failure
Anesthesia considerations for antiarrythmics Intraop concerns, management and D/C issues
Intraop concerns: Cardiac depression, prolonged neuromuscular blockade Management: Serum drug levels as needed, if on amio may need vasopressor, inotropes and pacemaker capability D/C issues: Rarely recommended to stop meds, withhold concurrent medications such as ACE-i
Anesthesia considerations for NSAIDS and anti platelet drugs Intraop concerns and D/C issues
Intraop concerns: impaired plt function, altered renal function, GI bleed D/C issues: Antiplatlet drugs such as aspirin, clopidogrel, ticlodipine should be d/c 7-10 days prior, NSAIDS can be continued the day of unless risk of bleeding is high
Anesthesia considerations for anticoagulants (heparin, coumadin, LMWH) Intraop concerns, management and D/C issues
Intraop concerns: Increased hemorrhage Management: Reverse heparin w/ protamine, revers coumadin with vitamin k or FFP D/C issues: Heparin IV 6 hours prior and check PTT, Coumadin 3-5 days prior, 5 if INR <1.5 needed, LMWH 12 hours prior to surgery
Anesthesia considerations for fibrinolytic (streptokinase, TPA, urokinase) Intraop concerns, management and D/C issues
Intraop concerns: Hemorrhage Management: Antifibrinolytics (aprotinin) may be indicated D/C issues: usually not an option
Anesthesia considerations for oral hypoglycemic agents Intraop concerns, management and D/C issues
Intraop concerns: Hyperglycemia/hypoglycemia Management: Avoid dehydration and monitor serum glucose D/C issues: Withhold oral agents the day of surgery
Anesthesia considerations for MOAI’s Intraop concerns, management and D/C issues
Intraop concerns: Hypertension secondary to norepinephrine release; meperidine causes excitatory state or depressive phenomena secondary to opioids Management: Avoid triggering agents such as meperidine, pentazocine, dextromethorphan and indirect sympathomimetics D/C issues: Irreversible MAOI’s 2 weeks prior w/ high risk of serious psychiatric consequences, reversible can be continued up to the day of surgery
Anesthesia considerations for TCA’s Intraop concerns, management and D/C issues
Intraop concerns: alpha blocking activity and potential to block norepinephrine reuptake potential for cardiac issues, lowers seizure threshold Management: norepinephrine should be considered the vasopressor of choice D/C issues: gradually over 2 weeks prior to surgery, obtain baseline ECG
Anesthesia considerations for Lithium Intraop concerns, management and D/C issues
Intraop concerns: Ventricular arryhthmias, atropine-resistant sinus brady, dehydration increases lithium levels Management: Hydration D/C issues: 72 hours prior to surgery
Neuraxial Anesthesia guidelines for LMWH (exonaparin, dalteparin, tinzaparin) When to hold before procedure/catheter removal, when to restart med after procedure/catheter removal, additional info and half-life
Before procedure: 24 hours, check anti factor Xa in elderly/renal insufficient Restart after procedure: 24-72 hours Before catheter removal: Should be removed before intiation of LMWH Restart after catheter removal: 4 hours prior to first post dose and at least 24 hours post neuraxial procedure Additional: Wait >24 hours after bloody tap to restart Half-life: 4-7 hours



























